Latest White Papers

The Laboratory Executive’s Guide to Maximizing Revenue & Valuation: Effective Revenue Cycle and Compliance Management are Critical Success Factors

There is no doubt that the complexity of laboratory revenue cycle management is unmatched in all of health care. With frequent regulatory and compliance rules changes, ever tightening margins, and a severely weakened economy, it is getting harder and harder for potentially acquirable independent labs to be sure they are not leaving potential profits on the table. The Dark Report is happy to offer our readers a chance to download our recently published White Paper “The Laboratory Executive’s Guide to Maximizing Revenue & Valuation: Effective Revenue Cycle and Compliance Management are Critical Success Factors” at absolutely no charge. This free download will provide readers with a detailed analysis of how laboratories can maximize reimbursement to increase revenue and valuation operating margin.

read more
A Lab Leader’s Guide To Pharmacogenomic Testing (PGx)

The Dark Report is pleased to offer this FREE White Paper, providing an enlightening overview of pharmacogenomic testing and how PGx fits into current healthcare goals, a discussion of the obstacles healthcare providers, institutions and clinical diagnostic laboratories face in entering the pharmacogenomic testing market, and examples of how a cloud-based, Software-as-a-Service platform can help healthcare providers overcome those obstacles.

read more
3 Critical Rules for Surviving in 2017: Your Medical Laboratory’s Guide to Thriving in Today’s Healthcare Landscape

With less revenue flowing from reimbursements and more consumers footing the bill for diagnostic testing, counterbalancing lost revenue while better serving providers and patients is not an option—it is a must. The Dark Report is pleased to offer this FREE White Paper, exploring three critical rules innovative medical laboratories must take into account to combat new and drastic changes occurring in the lab industry, and outlining proactive steps that when taken, will serve as the foundation for clinical success in 2017 and beyond.

read more
How Clinical Laboratories and Pathology Groups Can Succeed in Pharmacogenomics: What the Experts are Saying

Increasing understanding of the genetic basis of an individual’s response to drugs, including how and how quickly a drug is metabolized (pharmacodynamics and pharmacokinetics), has opened the door to an increasingly personalized approach to drug prescription. By identifying drugs most likely to benefit a patient, assessing the likely dose response, potentially avoiding adverse reactions, and reducing unnecessary use of drugs,  pharmacogenomics testing (PgX) is helping to optimize treatment and reduce costs associated with complications or inappropriate utilization.

read more
Molecular Information Management Systems (MIMS): Pathologists are Using MIMS To Revolutionize Personalized and Predictive Medicine

As molecular technology and personalized medicine increasingly becomes the default position for clinical diagnostics laboratories, these modalities place significant demands on laboratory information systems. Although hospitals and healthcare institutions often focus on an enterprise-wide electronic medical records system that includes a laboratory information system (LIS), those LIS’s do not typically have the functionality needed to handle current molecular testing needs, let alone those expected in the near future.

read more

Latest E-Briefings

Some Hospitals Launch Concierge Care Clinics to Raise Revenue, Generating both Controversy and Opportunity for Medical Laboratories

Critics are quick to note that this creates a disparity in how patients access healthcare services Independent concierge care (AKA concierge medicine) is available to anyone willing to pay the additional costs, which are over and above any health insurance. In a...

read more

KFF Study Finds HDHPs and Increased Cost-Sharing Requirements for Medical Services are Making Healthcare Increasingly Inaccessible to Consumers

Though ACA reforms may have slowed healthcare spending, rapidly increasing deductibles and cost sharing requirements have many experts questioning if patients can afford care at all, despite the increased availability of insurance coverage Much of the debate...

read more

Researchers at Several Top Universities Unveil CRISPR-Based Diagnostics That Show Great Promise for Clinical Laboratories

Three innovative technologies utilizing CRISPR-Cas13, Cas12a, and Cas9 demonstrate how CRISPR might be used for more than gene editing, while highlighting potential to develop new diagnostics for both the medical laboratory and point-of-care (POC) testing markets...

read more

What Makes US Healthcare So Expensive? It’s Price, Not Overutilization, Say Researchers at IHME and UCLA

Recent studies exploring the economics behind the high price of US healthcare independently point to the price of labor, goods, services, administrative costs, and pharmaceuticals as primary reason why the US spends almost twice as much as peer countries on healthcare...

read more

PwC Predicts Forces Shaping Healthcare in 2018; Some Could Impact Clinical Laboratories and Anatomic Pathology Groups

PwC’s list of 12 factors that will shape the healthcare landscape in 2018 calls attention to many new innovations Dark Daily has reported on that will impact how medical laboratories perform their tests PwC’s Health Research Institute (HRI) issued its annual report,...

read more

Kaiser Health News Labels Routine Clinical Laboratory Testing and Other Screening of Elderly Patients an ‘Epidemic’ in US

Some experts in medical community question value of health screenings of older patients with shortened life expectancies, though many aging adults are skeptical of calls to skip tests What does it mean when a credible health organization makes the assertion that there...

read more

New FDA Regulations of Clinical Decision-Support/Digital Health Applications and Medical Software Has Consequences for Medical Laboratories

Softened FDA regulation of both clinical-decision-support and patient-decision-support software applications could present opportunities for clinical laboratory developers of such tools Late 2017, the Food and Drug Administration (FDA) released guidelines on how the...

read more

Declining In-Patient Admission Rates Blamed on High-Deductible Health Plans; Could Impact Hospital-Based Medical Laboratories

Clinical laboratories may want to offset plunging patient lab specimens by increasing outreach business Hospital admissions are in decline across the country and the trend is being blamed in part on the rising use of high-deductible health plans (HDHP). The...

read more

Lab-on-a-Fiber Technology Continues to Highlight Nano-Scale Clinical Laboratory Diagnostic Testing in Point-of-Care Environments

Ever shrinking “lab-on-a-…” technologies, a boon to medical laboratories and anatomic pathologists in remote resource-strapped regions, also have a place in modern labs Researchers took another leap forward in reducing the size of clinical laboratory diagnostic tests...

read more

Latest Webinars

Don't miss out on important Lab Related news!

SUBSCRIBE TO OUR

E-Briefing Service

New developments, new technology, and changing healthcare trends make it imperative to stay informed to be successful.